Algeta ASA : US FDA Grants Priority Review to the New Drug Application for Radium-223 Dichloride for Castration-Resistant Prostate Cancer with Bone Metastases

World News: . []

Not Intended for US Media Oslo Norway 13 February 2013 - Algeta ASA OSE ALGETA announces that Bayer has received notification from the US Food and Drug Administration FDA granting priority review of the New Drug Application NDA filed in Decembe...

More news and information about Algeta ASA

Published By:

Thomson Reuters: 06:02 GMT Wednesday 13th February 2013

Published: .

Search for other references to "algeta" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers